Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments ...

Fintel reports that on June 17, 2025, Citigroup initiated coverage of Novavax (NasdaqGS:NVAX) with a Sell recommendation.

Wall Street’s major market averages seesawed back and forth on Friday and finished mixed as Federal Reserve Governor ...

Provincial health officials recommend that Nova Scotians 65 years and older get a dose of Covid-19 vaccine this spring. The ...

(In the weekly Health Matters newsletter, Ramya Kannan writes about getting to good health, and staying there. You can ...

The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug ...

In the wake of Robert F. Kennedy Jr.’s abrupt revamp of the CDC’s Advisory Committee on Immunization Practices, details from ...

Novavax (NVAX) is in focus after the company responded to the FDA's call for an additional clinical trial for its COVID-19 vaccine. Zscaler (ZS) was upgraded to Outperform from Neutral by BNP Paribas.

Novavax (NVAX) is in focus after the company responded to the FDA's call for an additional clinical trial for its COVID-19 vaccine. Zscaler (ZS) was upgraded to Outperform from Neutral by BNP Paribas.

Novavax (NVAX) is in focus after the company responded to the FDA's call for an additional clinical trial for its COVID-19 vaccine. Zscaler (ZS) was upgraded to Outperform from Neutral by BNP Paribas.

Novavax (NVAX) is in focus after the company responded to the FDA's call for an additional clinical trial for its COVID-19 vaccine. Zscaler (ZS) was upgraded to Outperform from Neutral by BNP Paribas.